Cargando…

Human Polycomb group EED protein negatively affects HIV-1 assembly and release

BACKGROUND: The human EED protein, a member of the superfamily of Polycomb group (PcG) proteins with WD-40 repeats, has been found to interact with three HIV-1 components, namely the structural Gag matrix protein (MA), the integrase enzyme (IN) and the Nef protein. The aim of the present study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakotobe, Dina, Tardy, Jean-Claude, André, Patrice, Hong, Saw See, Darlix, Jean-Luc, Boulanger, Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899515/
https://www.ncbi.nlm.nih.gov/pubmed/17547741
http://dx.doi.org/10.1186/1742-4690-4-37
_version_ 1782133948246130688
author Rakotobe, Dina
Tardy, Jean-Claude
André, Patrice
Hong, Saw See
Darlix, Jean-Luc
Boulanger, Pierre
author_facet Rakotobe, Dina
Tardy, Jean-Claude
André, Patrice
Hong, Saw See
Darlix, Jean-Luc
Boulanger, Pierre
author_sort Rakotobe, Dina
collection PubMed
description BACKGROUND: The human EED protein, a member of the superfamily of Polycomb group (PcG) proteins with WD-40 repeats, has been found to interact with three HIV-1 components, namely the structural Gag matrix protein (MA), the integrase enzyme (IN) and the Nef protein. The aim of the present study was to analyze the possible biological role of EED in HIV-1 replication, using the HIV-1-based vector HIV-Luc and EED protein expressed by DNA transfection of 293T cells. RESULTS: During the early phase of HIV-1 infection, a slight negative effect on virus infectivity occurred in EED-expressing cells, which appeared to be dependent on EED-MA interaction. At late times post infection, EED caused an important reduction of virus production, from 20- to 25-fold as determined by CAp24 immunoassay, to 10- to 80-fold based on genomic RNA levels, and this decrease was not due to a reduction of Gag protein synthesis. Coexpression of WTNef, or the non-N-myristoylated mutant NefG2A, restored virus yields to levels obtained in the absence of exogenous EED protein. This effect was not observed with mutant NefΔ57 mimicking the Nef core, or with the lipid raft-retargeted fusion protein LAT-Nef. LAT(AA)-Nef, a mutant defective in the lipid raft addressing function, had the same anti-EED effect as WTNef. Cell fractionation and confocal imaging showed that, in the absence of Nef, EED mainly localized in membrane domains different from the lipid rafts. Upon co-expression with WTNef, NefG2A or LAT(AA)-Nef, but not with NefΔ57 or LAT-Nef, EED was found to relocate into an insoluble fraction along with Nef protein. Electron microscopy of HIV-Luc producer cells overexpressing EED showed significant less virus budding at the cell surface compared to control cells, and ectopic assembly and clustering of nuclear pore complexes within the cytoplasm. CONCLUSION: Our data suggested that EED exerted an antiviral activity at the late stage of HIV-1 replication, which included genomic RNA packaging and virus assembly, resulting possibly from a mistrafficking of viral genomic RNA (gRNA) or gRNA/Gag complex. Nef reversed the EED negative effect on virus production, a function which required the integrity of the Nef N-terminal domain, but not its N-myristoyl group. The antagonistic effect of Nef correlated with a cellular redistribution of both EED and Nef.
format Text
id pubmed-1899515
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18995152007-06-27 Human Polycomb group EED protein negatively affects HIV-1 assembly and release Rakotobe, Dina Tardy, Jean-Claude André, Patrice Hong, Saw See Darlix, Jean-Luc Boulanger, Pierre Retrovirology Research BACKGROUND: The human EED protein, a member of the superfamily of Polycomb group (PcG) proteins with WD-40 repeats, has been found to interact with three HIV-1 components, namely the structural Gag matrix protein (MA), the integrase enzyme (IN) and the Nef protein. The aim of the present study was to analyze the possible biological role of EED in HIV-1 replication, using the HIV-1-based vector HIV-Luc and EED protein expressed by DNA transfection of 293T cells. RESULTS: During the early phase of HIV-1 infection, a slight negative effect on virus infectivity occurred in EED-expressing cells, which appeared to be dependent on EED-MA interaction. At late times post infection, EED caused an important reduction of virus production, from 20- to 25-fold as determined by CAp24 immunoassay, to 10- to 80-fold based on genomic RNA levels, and this decrease was not due to a reduction of Gag protein synthesis. Coexpression of WTNef, or the non-N-myristoylated mutant NefG2A, restored virus yields to levels obtained in the absence of exogenous EED protein. This effect was not observed with mutant NefΔ57 mimicking the Nef core, or with the lipid raft-retargeted fusion protein LAT-Nef. LAT(AA)-Nef, a mutant defective in the lipid raft addressing function, had the same anti-EED effect as WTNef. Cell fractionation and confocal imaging showed that, in the absence of Nef, EED mainly localized in membrane domains different from the lipid rafts. Upon co-expression with WTNef, NefG2A or LAT(AA)-Nef, but not with NefΔ57 or LAT-Nef, EED was found to relocate into an insoluble fraction along with Nef protein. Electron microscopy of HIV-Luc producer cells overexpressing EED showed significant less virus budding at the cell surface compared to control cells, and ectopic assembly and clustering of nuclear pore complexes within the cytoplasm. CONCLUSION: Our data suggested that EED exerted an antiviral activity at the late stage of HIV-1 replication, which included genomic RNA packaging and virus assembly, resulting possibly from a mistrafficking of viral genomic RNA (gRNA) or gRNA/Gag complex. Nef reversed the EED negative effect on virus production, a function which required the integrity of the Nef N-terminal domain, but not its N-myristoyl group. The antagonistic effect of Nef correlated with a cellular redistribution of both EED and Nef. BioMed Central 2007-06-04 /pmc/articles/PMC1899515/ /pubmed/17547741 http://dx.doi.org/10.1186/1742-4690-4-37 Text en Copyright © 2007 Rakotobe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rakotobe, Dina
Tardy, Jean-Claude
André, Patrice
Hong, Saw See
Darlix, Jean-Luc
Boulanger, Pierre
Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title_full Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title_fullStr Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title_full_unstemmed Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title_short Human Polycomb group EED protein negatively affects HIV-1 assembly and release
title_sort human polycomb group eed protein negatively affects hiv-1 assembly and release
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899515/
https://www.ncbi.nlm.nih.gov/pubmed/17547741
http://dx.doi.org/10.1186/1742-4690-4-37
work_keys_str_mv AT rakotobedina humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease
AT tardyjeanclaude humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease
AT andrepatrice humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease
AT hongsawsee humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease
AT darlixjeanluc humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease
AT boulangerpierre humanpolycombgroupeedproteinnegativelyaffectshiv1assemblyandrelease